Cover Image
市場調查報告書

亞洲的醫藥品、醫療產業 (季度更新報告)

Asia Pharmaceuticals and Healthcare Report Q2 2017

出版商 BMI Research 商品編碼 363588
出版日期 內容資訊 英文 37 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
亞洲的醫藥品、醫療產業 (季度更新報告) Asia Pharmaceuticals and Healthcare Report Q2 2017
出版日期: 2017年04月26日 內容資訊: 英文 37 Pages
簡介

本報告提供亞洲各國的製藥產業及醫療產業相關分析,地區整體產業規模的實際成果值、預測值 (過去5年、今後10年份) 估計,產業的課題 (風險) 和未來性的商機 (利潤) 相關評估,域內各地區詳細趨勢,主要企業簡介等資訊彙整,為您概述為以下內容

BMI產業分析

  • 亞洲市場最新形勢

SWOT分析

  • 亞洲市場最新形勢

產業預測

  • 醫藥品市場最新形勢
  • 醫療市場最新形勢

產業的風險/利潤指標

  • 亞洲:風險/利潤指標

市場概況

  • 亞洲市場最新形勢

產業的趨勢與發展

  • 亞洲市場最新形勢

域內市場概況

  • 亞洲市場最新形勢

詞彙表

分析方法

  • 醫藥品支出額的預測模式
  • 醫療費的預測模式
  • 分析方法的相關註記
  • 風險/利潤指標技術
  • 指標概要
  • 指標的加權

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 2398-1016

BMI View:Acts undertaken by US President Donald Trump will shape the Asia Pacific's pharmaceutical sectors. The withdrawal of the US from the Trans-Pacific Partnership is particularly significant, passing up an opportunity to introduce strong intellectual property protections which would have had ramifications beyond the original seven Asia Pacific member states. Trump's push to encourage the domestic manufacture of drugs will also affect pharmaceutical exporters in the region, with India being the most exposed - 38% of its total medicine exports went to the US in 2015.

Healthcare Expenditure Forecasts

  • Pharmaceuticals: USD303bn in 2016 to USD307bn in 2017; 1.3% y-o-y increase in US dollar terms.
  • Healthcare: USD1,690bn in 2016 to USD1,736bn by 2017; a 2.7% y-o-y increase in US dollar terms.

Risk/Reward Index

The Asia Pacific average in our Innovative Pharmaceuticals Risk/Reward Index (RRI) outperforms the global average by a small but significant margin. This is because the region comprises of two of the world's largest pharmaceutical markets, and is boosted by the significant growth potential of several emerging markets.

Table of Contents

BMI Industry View

  • Table: Headline Regional Pharmaceuticals & Healthcare Forecasts (Asia (Region) 2015-2021)

SWOT

Industry Forecast

  • Pharmaceutical Market Forecast
    • Table: Regional Pharmaceutical Sales, Historical Data And Forecasts (Asia (Region) 2013-2021)
  • Healthcare Market Forecast
    • Table: Regional Healthcare Expenditure Trends, Historical Data And Forecasts (Asia (Region) 2013-2021)

Industry Risk Reward Index

  • Asia Pacific Risk/Reward Index

Market Overview

Industry Trends and Developments

  • Industry Trends And Developments

Regional Overview

  • Asia - Q2 2017
    • Table: Asia Pharmaceutical Market (USDbn)

Glossary

Methodology

  • Pharmaceutical Expenditure Forecast Model
  • Healthcare Expenditure Forecast Model
  • Notes On Methodology
  • Risk/Reward Index Methodology
    • Table: Indicators - Rationale And Sources
Back to Top